{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:39:35Z","timestamp":1758638375481},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T00:00:00Z","timestamp":1212537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10633-008-9132-y","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T10:08:53Z","timestamp":1212487733000},"page":"257-261","source":"Crossref","is-referenced-by-count":16,"title":["Total rod ERG suppression with high dose compassionate Fenretinide usage"],"prefix":"10.1007","volume":"117","author":[{"given":"Michael F.","family":"Marmor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"Moshfeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,4]]},"reference":[{"key":"9132_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(92)81046-O","volume":"308","author":"R Berni","year":"1992","unstructured":"Berni R, Formelli F (1992) In vitro interaction of Fenretinide with plasma retinol-binding protein and its functional consequences. Fed European Biochemical Soc 308:43\u201345","journal-title":"Fed European Biochemical Soc"},{"key":"9132_CR2","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1167\/iovs.05-0820","volume":"46","author":"RA Radu","year":"2007","unstructured":"Radu RA, Han Y, Bui TV, Nusinowitz S, Bok D, Lichter J, Widder K, Travis GH, Mata NL (2007) Reductions in serum Vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 46:4393\u20134401","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9132_CR3","first-page":"6149","volume":"49","author":"F Formelli","year":"1989","unstructured":"Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M (1989) Plasma retinol level reduction by the synthetic retinoid Fenretinide: A one year follow-up study of breast cancer patients. Cancer Res 49:6149\u20136152","journal-title":"Cancer Res"},{"key":"9132_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.1986.01050130079024","volume":"104","author":"MI Kaiser-Kupfer","year":"1986","unstructured":"Kaiser-Kupfer MI, Peck GL, Caruso RC, Jaffe MJ, DiGiovanna JJ, Gross EG (1986) Abnormal retinal function associated with Fenretinide, a synthetic retinoid. Arch Ophthalmol 104:69\u201370","journal-title":"Arch Ophthalmol"},{"key":"9132_CR5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/jnci\/82.12.1063","volume":"82","author":"MR Modiano","year":"1990","unstructured":"Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL Jr (1990) Ocular toxic effects of Fenretinide. J Natl Cancer Inst 82:1063","journal-title":"J Natl Cancer Inst"},{"key":"9132_CR6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01214648","volume":"91","author":"R Krzeminski","year":"1996","unstructured":"Krzeminski R, Zwas F, Esper P, Pienta K (1996) Electroretinographic findings in subjects after administration of Fenretinide. Doc Ophthalmol 91:299\u2013309","journal-title":"Doc Ophthalmol"},{"key":"9132_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0959-8049(96)00351-6","volume":"33","author":"A Decensi","year":"1997","unstructured":"Decensi A, Fontana V, Fioretto M, Rondanina G, Torrisi R, Orengo MA, Costa A (1997) Long-term effects of Fenretinide on retinal function. Eur J Cancer 33:80\u201384","journal-title":"Eur J Cancer"},{"key":"9132_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/86.2.105","volume":"86","author":"A Decensi","year":"1994","unstructured":"Decensi A, Torrisi R, Polizzi A, Gesi R, Brezzo V, Rolando M, Rondanina G, Orengo MA, Formelli F, Costa A (1994) Effect of the synthetic retinoid Fenretinide on dark adaptation and the ocular surface. J Natl Cancer Inst 86:105\u2013111","journal-title":"J Natl Cancer Inst"},{"key":"9132_CR9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archopht.116.6.759","volume":"116","author":"RC Caruso","year":"1998","unstructured":"Caruso RC, Zujewski J, Iwata F, Podgor MJ, Conley BA, Ayres LM, Kaiser-Kupfer MI (1998) Effects of Fenretinide (4-HPR) on dark adaptation. Arch Ophthalmol 116:759\u2013763","journal-title":"Arch Ophthalmol"},{"key":"9132_CR10","first-page":"369","volume":"24","author":"L Baglietto","year":"2000","unstructured":"Baglietto L, Torrisi R, Arena G, Tosetti F, Gonzaga A, Pasquetti W, Robertson C, Decensi A (2000) Ocular effects of Fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer. Cancer Detect Prev 24:369\u2013375","journal-title":"Cancer Detect Prev"},{"key":"9132_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3835(03)00108-3","volume":"197","author":"CP Reynolds","year":"2003","unstructured":"Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ (2003) Retinoid therapy of high-risk neuroblastoma. Cancer Lett 197:185\u2013192","journal-title":"Cancer Lett"},{"key":"9132_CR12","first-page":"2032","volume":"9","author":"A Garaventa","year":"2003","unstructured":"Garaventa A, Luksch R, LoPiccolo M, Cavadini E, Montaldo PG, Pizzitola R, Boni L, Ponzoni M, Decensi A, DeBernardi B, Bellani F, Formelli F (2003) Phase I trial and pharmacokinetics of Fenretinide in children with neuroblastoma. Clin Cancer Res 9:2032\u20132039","journal-title":"Clin Cancer Res"},{"key":"9132_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/B:DOOP.0000036793.44912.45","volume":"108","author":"MF Marmor","year":"2004","unstructured":"Marmor MF, Holder GE, Seeliger M, Yamamoto S (2004) Standard for clinical electroretinography (2004 Update). Doc Ophthalmol 108:107\u2013114","journal-title":"Doc Ophthalmol"},{"key":"9132_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.eye.6702212","volume":"21","author":"VA McBain","year":"2007","unstructured":"McBain VA, Egan CA, Pieris SI, Supramaniam G, Webster AR, Bird AC, Holder GE (2007) Functional observations in vitamin A deficiency: diagnosis and time course of recovery. Eye 21:367\u2013376","journal-title":"Eye"},{"key":"9132_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-6273(02)00937-6","volume":"36","author":"NL Mata","year":"2002","unstructured":"Mata NL, Radu RA, Clemmons RC, Travis GH (2002) Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight. Neuron 36:1\u20133","journal-title":"Neuron"},{"key":"9132_CR16","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/jn\/135.11.2512","volume":"135","author":"J Raila","year":"2007","unstructured":"Raila J, Willnow TE, Schweigert FJ (2007) Megalin-mediated reuptake of retinol in the kidneys of mice is essential for vitamin A homeostasis. J Nutr 135:2512\u20132516","journal-title":"J Nutr"},{"key":"9132_CR17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.1136244","volume":"315","author":"R Kawaguchi","year":"2007","unstructured":"Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D, Sun H (2007) A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315:820\u2013825","journal-title":"Science"},{"key":"9132_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.exer.2007.05.003","volume":"85","author":"A Muniz","year":"2007","unstructured":"Muniz A, Villazana-Espinoza ET, Hatch AL, Trevino SG, Allen DM, Tsin AT (2007) A novel cone visual cycle in the cone-dominated retina. Exp Eye Res 85:175\u2013184","journal-title":"Exp Eye Res"},{"key":"9132_CR19","first-page":"3","volume":"40","author":"MW Seeliger","year":"1999","unstructured":"Seeliger MW, Biesalski HK, Wissinger B, Gollnick H, Gielen S, Frank J, Beck S, Zrenner E (1999) Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthalmol Vis Sci 40:3\u201311","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-008-9132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-008-9132-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-008-9132-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:00:28Z","timestamp":1559232028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-008-9132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,4]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9132"],"URL":"https:\/\/doi.org\/10.1007\/s10633-008-9132-y","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,4]]}}}